BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 993829 O=c1[nH]c2cnccc2c(N2CCC3(CCC3)CC2)c1C#N InChI=1S/C17H18N4O/c18-10-13-15(12-2-7-19-11-14(12)20-16(13)22)21-8-5-17(6-9-21)3-1-4-17/h2,7,11H,1,3-6,8-9H2,(H,20,22) CSLJPLBMCWFQAN-UHFFFAOYSA-N 477937 2-oxo-4-(7-azaspiro[3.5]nonane-7-yl)-1,2-dihydro-1,7-naphthyridin-3-carbonitrile ::US10889591, Compound 16::US11434248, Compound 16 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 46.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477937 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477937&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027072 442137551 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993830 O=c1[nH]c2cnccc2c(N2CC[C@H](C2)n2cccn2)c1C#N 477938 US10889591, Compound 19::US11434248, Compound 19 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 28.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477938 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477938&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027073 442137552 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993831 Clc1cc2c(N3CC[C@H](C3)n3cccn3)c(C#N)c(=O)[nH]c2cn1 477939 US10889591, Compound 23::US11434248, Compound 23 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 13.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477939 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477939&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027074 442137553 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993832 O=c1[nH]c2cnccc2c(N2CCC3(COC3)CC2)c1C#N InChI=1S/C16H16N4O2/c17-7-12-14(11-1-4-18-8-13(11)19-15(12)21)20-5-2-16(3-6-20)9-22-10-16/h1,4,8H,2-3,5-6,9-10H2,(H,19,21) DFDIFIMXNPUJKH-UHFFFAOYSA-N 477940 US10889591, Compound 24::US11434248, Compound 24 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 14.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477940 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477940&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027075 442137554 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993833 O=c1[nH]c2cnccc2c(N2CCC3(CC3)CC2)c1C#N InChI=1S/C16H16N4O/c17-9-12-14(20-7-4-16(2-3-16)5-8-20)11-1-6-18-10-13(11)19-15(12)21/h1,6,10H,2-5,7-8H2,(H,19,21) LGZFQNJXGXCQLM-UHFFFAOYSA-N 477941 2-oxo-4-(6-azaspiro[2.5]octane-6-yl)-1,2-dihydro-1,7-naphthyridin-3-carbonitrile ::US10889591, Compound 25::US11434248, Compound 25 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 29.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477941 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477941&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027076 442137555 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993834 CCc1ccc(cc1)-c1c(C#N)c(=O)[nH]c2cnccc12 InChI=1S/C17H13N3O/c1-2-11-3-5-12(6-4-11)16-13-7-8-19-10-15(13)20-17(21)14(16)9-18/h3-8,10H,2H2,1H3,(H,20,21) GZGJZGODPLODIC-UHFFFAOYSA-N 477942 4-(4-ethylphenyl)-2-oxo-1,2-dihydro-1,7-naphthyridin-3-carbonitrile ::US10889591, Compound 26::US11434248, Compound 26 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 10.00 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477942 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477942&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027077 442137556 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993835 Cc1cc2c(N3CC[C@H](C3)n3cccn3)c(C#N)c(=O)[nH]c2cn1 477943 US10889591, Compound 27::US11434248, Compound 27 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 12.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477943 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477943&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027078 442137557 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993836 CSc1cc2c(N3CCC4(CCC4)CC3)c(C#N)c(=O)[nH]c2cn1 InChI=1S/C18H20N4OS/c1-24-15-9-12-14(11-20-15)21-17(23)13(10-19)16(12)22-7-5-18(6-8-22)3-2-4-18/h9,11H,2-8H2,1H3,(H,21,23) CAKCIHIOFCXKFA-UHFFFAOYSA-N 477944 US10889591, Compound 30::US11434248, Compound 30 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 8.00 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477944 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477944&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027079 442137558 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993837 OCC(O)c1cc2c(N3CCC4(CC4)CC3)c(C#N)c(=O)[nH]c2cn1 477945 6-(1,2-dihydroxyethyl)-2-oxo-4-(6-azaspiro[2.5]octane-6-yl)-1,2-dihydro-1,7-naphthyridin-3-carbonitrile ::US10889591, Compound 32::US11434248, Compound 32 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 22.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477945 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477945&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027080 442137559 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993838 OCC(O)c1cc2c(N3CCC4(CCC4)CC3)c(C#N)c(=O)[nH]c2cn1 477946 US10889591, Compound 33::US11434248, Compound 33 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 10.00 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477946 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477946&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027081 442137560 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993839 O=c1[nH]c2cnc(cc2c(N2CC[C@H](C2)n2cccn2)c1C#N)N1CCOCC1 477947 (R)-4-(3-(1H-pyrazol-1-yl)pyrrolidin-1-yl)-6-morpholino-2-oxo-1,2-dihydro-1,7-naphthyridin-3-carbonitrile ::US10889591, Compound 39::US11434248, Compound 39 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 25.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477947 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477947&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027082 442137561 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993840 Nc1cc2c(N3CCC4(CC4)CC3)c(C#N)c(=O)[nH]c2cn1 InChI=1S/C16H17N5O/c17-8-11-14(21-5-3-16(1-2-16)4-6-21)10-7-13(18)19-9-12(10)20-15(11)22/h7,9H,1-6H2,(H2,18,19)(H,20,22) CKEUNRZPTNFNMI-UHFFFAOYSA-N 477948 6-amino-2-oxo-4-(6-azaspiro[2.5]octane-6-yl)-1,2-dihydro-1,7-naphthyridin-3-carbonitrile ::US10889591, Compound 44::US11434248, Compound 44 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 71.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477948 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477948&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027083 442137562 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993841 CNc1cc2c(N3CCC4(CC4)CC3)c(C#N)c(=O)[nH]c2cn1 InChI=1S/C17H19N5O/c1-19-14-8-11-13(10-20-14)21-16(23)12(9-18)15(11)22-6-4-17(2-3-17)5-7-22/h8,10H,2-7H2,1H3,(H,19,20)(H,21,23) VXRDINXMCBFMQN-UHFFFAOYSA-N 477949 6-methylamino-2-oxo-4-(6-azaspiro[2.5]octane-6-yl)-1,2-dihydro-1,7-naphthyridin-3-carbonitrile ::US10889591, Compound 45::US11434248, Compound 45 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 37.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477949 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477949&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027084 442137563 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993842 CN(C)c1cc2c(N3CCC4(CC4)CC3)c(C#N)c(=O)[nH]c2cn1 InChI=1S/C18H21N5O/c1-22(2)15-9-12-14(11-20-15)21-17(24)13(10-19)16(12)23-7-5-18(3-4-18)6-8-23/h9,11H,3-8H2,1-2H3,(H,21,24) XUVZIPQRFGZHFI-UHFFFAOYSA-N 477950 6-dimethylamino-2-oxo-4-(6-azaspiro[2.5]octane-6-yl)-1,2-dihydro-1,7-naphthyridin-3-carbonitrile ::US10889591, Compound 46::US11434248, Compound 46 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 18.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477950 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477950&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027085 442137564 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993843 CN(C)c1cc2c(N3CCC4(CCC4)CC3)c(C#N)c(=O)[nH]c2cn1 InChI=1S/C19H23N5O/c1-23(2)16-10-13-15(12-21-16)22-18(25)14(11-20)17(13)24-8-6-19(7-9-24)4-3-5-19/h10,12H,3-9H2,1-2H3,(H,22,25) YETRDDMTTQAQNM-UHFFFAOYSA-N 477951 6-isopropyl-2-oxo-4-(7-azaspiro[3.5]nonane-7-yl)-1,2-dihydro-1,7-naphthyridin-3-carbonitrile ::US10889591, Compound 47::US11434248, Compound 47 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 12.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477951 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477951&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027086 442137565 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993844 O=c1[nH]c2cnc(cc2c(N2CCC3(CC3)CC2)c1C#N)N1CCC1 InChI=1S/C19H21N5O/c20-11-14-17(24-8-4-19(2-3-19)5-9-24)13-10-16(23-6-1-7-23)21-12-15(13)22-18(14)25/h10,12H,1-9H2,(H,22,25) QSIDSDJECMFSTD-UHFFFAOYSA-N 477952 6-(azetidin-1-yl)-2-oxo-4-(6-azaspiro[2.5]octane-6-yl)-1,2-dihydro-1,7-naphthyridin-3-carbonitrile ::US10889591, Compound 49::US11434248, Compound 49 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 9.00 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477952 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477952&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027087 442137566 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993845 OC1CN(C1)c1cc2c(N3CCC4(CC4)CC3)c(C#N)c(=O)[nH]c2cn1 InChI=1S/C19H21N5O2/c20-8-14-17(23-5-3-19(1-2-19)4-6-23)13-7-16(24-10-12(25)11-24)21-9-15(13)22-18(14)26/h7,9,12,25H,1-6,10-11H2,(H,22,26) OSMKVKHNVDEFLA-UHFFFAOYSA-N 477953 6-(3-hydroxyazetidin-1-yl)-2-oxo-4-(6-azaspiro[2.5]octane-6-yl)-1,2-dihydro-1,7-naphthyridin-3-carbonitrile ::US10889591, Compound 50::US11434248, Compound 50 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 19.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477953 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477953&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027088 442137567 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993846 OC1CN(C1)c1cc2c(N3CCC4(CCC4)CC3)c(C#N)c(=O)[nH]c2cn1 InChI=1S/C20H23N5O2/c21-9-15-18(24-6-4-20(5-7-24)2-1-3-20)14-8-17(25-11-13(26)12-25)22-10-16(14)23-19(15)27/h8,10,13,26H,1-7,11-12H2,(H,23,27) KMHDGBBPVHERFL-UHFFFAOYSA-N 477954 6-(3-hydroxyazetidin-1-yl)-2-oxo-4-(7-azaspiro[3.5]nonane-7-yl)-1,2-dihydro-1,7-naphthyridin-3-carbonitrile ::US10889591, Compound 51::US11434248, Compound 51 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 5.00 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477954 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477954&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027089 442137568 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993847 NC1CN(C1)c1cc2c(N3CCC4(CC4)CC3)c(C#N)c(=O)[nH]c2cn1 InChI=1S/C19H22N6O/c20-8-14-17(24-5-3-19(1-2-19)4-6-24)13-7-16(25-10-12(21)11-25)22-9-15(13)23-18(14)26/h7,9,12H,1-6,10-11,21H2,(H,23,26) VQUSOODLBVCGGP-UHFFFAOYSA-N 477955 US10889591, Compound 52::US11434248, Compound 52 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 36.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477955 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477955&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027090 442137569 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993848 NC1CN(C1)c1cc2c(N3CCC4(CCC4)CC3)c(C#N)c(=O)[nH]c2cn1 InChI=1S/C20H24N6O/c21-9-15-18(25-6-4-20(5-7-25)2-1-3-20)14-8-17(26-11-13(22)12-26)23-10-16(14)24-19(15)27/h8,10,13H,1-7,11-12,22H2,(H,24,27) YYCWEGUSOXVARL-UHFFFAOYSA-N 477956 US10889591, Compound 53::US11434248, Compound 53 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 15.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477956 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477956&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027091 442137570 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993849 O=c1[nH]c2cnc(cc2c(N2CCC3(CCC3)CC2)c1C#N)N1CCC1 InChI=1S/C20H23N5O/c21-12-15-18(25-9-5-20(6-10-25)3-1-4-20)14-11-17(24-7-2-8-24)22-13-16(14)23-19(15)26/h11,13H,1-10H2,(H,23,26) GSDRCGJJHSGDHT-UHFFFAOYSA-N 477957 6-(azetidin-1-yl)-2-oxo-4-(7-azaspiro[3.5]nonane-7-yl)-1,2-dihydro-1,7-naphthyridin-3-carbonitrile ::US10889591, Compound 54::US11434248, Compound 54 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 22.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477957 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477957&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027092 442137571 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993850 C=Cc1cc2c(N3CCC4(CC4)CC3)c(C#N)c(=O)[nH]c2cn1 InChI=1S/C18H18N4O/c1-2-12-9-13-15(11-20-12)21-17(23)14(10-19)16(13)22-7-5-18(3-4-18)6-8-22/h2,9,11H,1,3-8H2,(H,21,23) OISXWTBTFZWLEQ-UHFFFAOYSA-N 477958 US10889591, Compound 58::US11434248, Compound 58 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 44.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477958 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477958&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027093 442137572 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993851 O=c1[nH]c2cnc(cc2c(N2CCC3(CC3)CC2)c1C#N)C1CC1 InChI=1S/C19H20N4O/c20-10-14-17(23-7-5-19(3-4-19)6-8-23)13-9-15(12-1-2-12)21-11-16(13)22-18(14)24/h9,11-12H,1-8H2,(H,22,24) BHIMBQYAZUUQAP-UHFFFAOYSA-N 477959 6-cyclopropyl-2-oxo-4-(6-azaspiro[2.5]octane-6-yl)-1,2-dihydro-1,7-naphthyridin-3-carbonitrile ::US10889591, Compound 59::US11434248, Compound 59 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 57.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477959 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477959&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027094 442137573 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993852 O=c1[nH]c2cnc(cc2c(N2CCC3(CCC3)CC2)c1C#N)C1CC1 InChI=1S/C20H22N4O/c21-11-15-18(24-8-6-20(7-9-24)4-1-5-20)14-10-16(13-2-3-13)22-12-17(14)23-19(15)25/h10,12-13H,1-9H2,(H,23,25) RAJAKUIIXAWIFY-UHFFFAOYSA-N 477960 6-cyclopropyl-2-oxo-4-(7-azaspiro[3.5]nonane-7-yl)-1,2-dihydro-1,7-naphthyridin-3-carbonitrile ::US10889591, Compound 60::US11434248, Compound 60 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 43.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477960 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477960&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027095 442137574 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993853 OCc1cc2c(N3CCC4(CC4)CC3)c(C#N)c(=O)[nH]c2cn1 InChI=1S/C17H18N4O2/c18-8-13-15(21-5-3-17(1-2-17)4-6-21)12-7-11(10-22)19-9-14(12)20-16(13)23/h7,9,22H,1-6,10H2,(H,20,23) JTJBKUMYOIAXIE-UHFFFAOYSA-N 477961 6-(hydroxymethyl)-2-oxo-4-(6-azaspiro[2.5]octane-6-yl)-1,2-dihydro-1,7-naphthyridin-3-carbonitrile ::US10889591, Compound 62::US11434248, Compound 62 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 19.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477961 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477961&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027096 442137575 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993854 Cc1cc2c(N3CCC4(CC4)CC3)c(C#N)c(=O)[nH]c2cn1 InChI=1S/C17H18N4O/c1-11-8-12-14(10-19-11)20-16(22)13(9-18)15(12)21-6-4-17(2-3-17)5-7-21/h8,10H,2-7H2,1H3,(H,20,22) FPUSOONDGMAQED-UHFFFAOYSA-N 477962 6-methyl-2-oxo-4-(6-azaspiro[2.5]octane-6-yl)-1,2-dihydro-1,7-naphthyridin-3-carbonitrile ::US10889591, Compound 63::US11434248, Compound 63 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 9.00 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477962 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477962&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027097 442137576 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993855 COc1cc2c(N3CCC4(CC4)CC3)c(C#N)c(=O)[nH]c2cn1 InChI=1S/C17H18N4O2/c1-23-14-8-11-13(10-19-14)20-16(22)12(9-18)15(11)21-6-4-17(2-3-17)5-7-21/h8,10H,2-7H2,1H3,(H,20,22) DSRUCJAYTORBBQ-UHFFFAOYSA-N 477963 6-methoxy-2-oxo-4-(6-azaspiro[2.5]octane-6-yl)-1,2-dihydro-1,7-naphthyridin-3-carbonitrile ::US10889591, Compound 64::US11434248, Compound 64 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 14.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477963 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477963&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027098 442137577 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993856 Cc1cc2c(N3CCC4(CCC4)CC3)c(C#N)c(=O)[nH]c2cn1 InChI=1S/C18H20N4O/c1-12-9-13-15(11-20-12)21-17(23)14(10-19)16(13)22-7-5-18(6-8-22)3-2-4-18/h9,11H,2-8H2,1H3,(H,21,23) UPGBJEXATQBXME-UHFFFAOYSA-N 477964 6-methyl-2-oxo-4-(7-azaspiro[3.5]nonane-7-yl)-1,2-dihydro-1,7-naphthyridin-3-carbonitrile ::US10889591, Compound 65::US11434248, Compound 65 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 13.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477964 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477964&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027099 442137578 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993857 COc1cc2c(N3CCC4(CCC4)CC3)c(C#N)c(=O)[nH]c2cn1 InChI=1S/C18H20N4O2/c1-24-15-9-12-14(11-20-15)21-17(23)13(10-19)16(12)22-7-5-18(6-8-22)3-2-4-18/h9,11H,2-8H2,1H3,(H,21,23) AYWIZVKWPITJPV-UHFFFAOYSA-N 477965 US10889591, Compound 66::US11434248, Compound 66 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 21.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477965 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477965&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027100 442137579 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993858 CCc1cc2c(N3CCC4(CC4)CC3)c(C#N)c(=O)[nH]c2cn1 InChI=1S/C18H20N4O/c1-2-12-9-13-15(11-20-12)21-17(23)14(10-19)16(13)22-7-5-18(3-4-18)6-8-22/h9,11H,2-8H2,1H3,(H,21,23) UCBWGXCILHAYLR-UHFFFAOYSA-N 477966 6-ethyl-2-oxo-4-(6-azaspiro[2.5]octane-6-yl)-1,2-dihydro-1,7-naphthyridin-3-carbonitrile ::US10889591, Compound 76::US11434248, Compound 76 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 16.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477966 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477966&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027101 442137580 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993859 O=c1[nH]c2cnc(cc2c(N2CCC3(CCC3)CC2)c1C#N)C#N InChI=1S/C18H17N5O/c19-9-12-8-13-15(11-21-12)22-17(24)14(10-20)16(13)23-6-4-18(5-7-23)2-1-3-18/h8,11H,1-7H2,(H,22,24) QLKNNMBTNMEQPJ-UHFFFAOYSA-N 477967 US10889591, Compound 77::US11434248, Compound 77 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 33.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477967 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477967&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027102 442137581 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993860 NCc1cc2c(N3CCC4(CCC4)CC3)c(C#N)c(=O)[nH]c2cn1 InChI=1S/C18H21N5O/c19-9-12-8-13-15(11-21-12)22-17(24)14(10-20)16(13)23-6-4-18(5-7-23)2-1-3-18/h8,11H,1-7,9,19H2,(H,22,24) TVSVLGNIJDHUDM-UHFFFAOYSA-N 477968 6-(aminomethyl)-2-oxo-4-(7-azaspiro[3.5]nonane-7-yl)-1,2-dihydro-1,7-naphthyridin-3-carbonitrile trifluoroacetate ::US10889591, Compound 78 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 33.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477968 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477968&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027103 442137582 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993861 CSc1cc2c(N3CCC4(CC4)CC3)c(C#N)c(=O)[nH]c2cn1 InChI=1S/C17H18N4OS/c1-23-14-8-11-13(10-19-14)20-16(22)12(9-18)15(11)21-6-4-17(2-3-17)5-7-21/h8,10H,2-7H2,1H3,(H,20,22) JWFUWTAFCVIBRM-UHFFFAOYSA-N 477969 US10889591, Compound 79::US11434248, Compound 79 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 12.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477969 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477969&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027104 442137583 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993862 O=c1[nH]c2cccnc2c(N2CCC3(CC3)CC2)c1C#N InChI=1S/C16H16N4O/c17-10-11-14(20-8-5-16(3-4-16)6-9-20)13-12(19-15(11)21)2-1-7-18-13/h1-2,7H,3-6,8-9H2,(H,19,21) AQZGAQZUOMWCOV-UHFFFAOYSA-N 477970 US10889591, Compound 80::US11434248, Compound 80 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 20.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477970 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477970&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027105 442137584 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993863 COC1(C)CCN(CC1)c1c(C#N)c(=O)[nH]c2cnccc12 InChI=1S/C16H18N4O2/c1-16(22-2)4-7-20(8-5-16)14-11-3-6-18-10-13(11)19-15(21)12(14)9-17/h3,6,10H,4-5,7-8H2,1-2H3,(H,19,21) ULLUPORPPZNVTN-UHFFFAOYSA-N 477971 4-(4-methoxy-4-methylpiperidin-1-yl)-2-oxo-1,2-dihydro-1,7-naphthyridin-3-carbonitrile ::US10889591, Compound 81::US11434248, Compound 81 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 42.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477971 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477971&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027106 442137585 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993864 CC(C)(O)c1cc2c(N3CCC4(CCC4)CC3)c(C#N)c(=O)[nH]c2cn1 InChI=1S/C20H24N4O2/c1-19(2,26)16-10-13-15(12-22-16)23-18(25)14(11-21)17(13)24-8-6-20(7-9-24)4-3-5-20/h10,12,26H,3-9H2,1-2H3,(H,23,25) RDUJODPOAPDJJD-UHFFFAOYSA-N 477973 US10889591, Compound 82::US11434248, Compound 82 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 29.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477973 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477973&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027107 442137587 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993865 OC(=O)c1cc2c(N3CCC4(CC4)CC3)c(C#N)c(=O)[nH]c2cn1 InChI=1S/C17H16N4O3/c18-8-11-14(21-5-3-17(1-2-17)4-6-21)10-7-12(16(23)24)19-9-13(10)20-15(11)22/h7,9H,1-6H2,(H,20,22)(H,23,24) FYIAXMMZQGTMLG-UHFFFAOYSA-N 477974 3-cyano-2-oxo-4-(6-azaspiro[2.5]octane-6-yl)-1,2-dihydro-1,7-naphthyridin-6-carboxylic acid ::US10889591, Compound 83::US11434248, Compound 83 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 8.00 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477974 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477974&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027108 442137588 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993866 CC(C)(O)c1cc2c(N3CCC4(CC4)CC3)c(C#N)c(=O)[nH]c2cn1 InChI=1S/C19H22N4O2/c1-18(2,25)15-9-12-14(11-21-15)22-17(24)13(10-20)16(12)23-7-5-19(3-4-19)6-8-23/h9,11,25H,3-8H2,1-2H3,(H,22,24) LEDJLECGFYIDFS-UHFFFAOYSA-N 477975 6-(2-hydroxypropan-2-yl)-2-oxo-4-(6-azaspiro[2.5]octane-6-yl)-1,2-dihydro-1,7-naphthyridin-3-carbonitrile ::US10889591, Compound 84::US11434248, Compound 84 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 78.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477975 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477975&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027109 442137589 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993867 OCc1cc2c(N3CCC4(CCC4)CC3)c(C#N)c(=O)[nH]c2cn1 InChI=1S/C18H20N4O2/c19-9-14-16(22-6-4-18(5-7-22)2-1-3-18)13-8-12(11-23)20-10-15(13)21-17(14)24/h8,10,23H,1-7,11H2,(H,21,24) KPDFCTYLAZBUQN-UHFFFAOYSA-N 477976 US10889591, Compound 85::US11434248, Compound 85 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 8.00 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477976 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477976&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027110 442137590 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993868 CC(O)c1cc2c(N3CCC4(CC4)CC3)c(C#N)c(=O)[nH]c2cn1 477977 US10889591, Compound 87::US11434248, Compound 87 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 13.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477977 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477977&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 138518524 442137591 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993869 OC(C1CC1)c1cc2c(N3CCC4(CC4)CC3)c(C#N)c(=O)[nH]c2cn1 477978 6-(cyclopropyl (hydroxy)methyl)-2-oxo-4-(6-azaspiro[2.5]octane-6-yl)-1,2-dihydro-1,7-naphthyridin-3-carbonitrile ::US10889591, Compound 90::US11434248, Compound 90 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 17.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477978 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477978&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027111 442137592 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993870 OC(C#C)c1cc2c(N3CCC4(CC4)CC3)c(C#N)c(=O)[nH]c2cn1 477979 6-(1-hydroxyprop-2-yn-1-yl)-2-oxo-4-(6-azaspiro[2.5]octane-6-yl)-1,2-dihydro-1,7-naphthyridin-3-carbonitrile ::US10889591, Compound 91::US11434248, Compound 91 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 47.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477979 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477979&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027112 442137593 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993871 OC(c1cc2c(N3CCC4(CC4)CC3)c(C#N)c(=O)[nH]c2cn1)C(F)(F)F 477980 2-oxo-4-(6-azaspiro[2.5]octane-6-yl)-6-(2,2,2-trifluoro-1-hydroxyethyl)-1,2-dihydro-1,7-naphthyridin-3-carbonitrile ::US10889591, Compound 92::US11434248, Compound 92 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 83.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477980 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477980&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027113 442137594 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993872 CC(OC(C)=O)c1cc2c(N3CCC4(CC4)CC3)c(C#N)c(=O)[nH]c2cn1 477981 US10889591, Compound 93::US11434248, Compound 93::ethyl 1-(3-cyano-2-oxo-4-(6-azaspiro[2.5]octane-6-yl)-1,2-dihydro-1,7-naphthyridin-6-yl) Acetate High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 86.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477981 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477981&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027114 442137595 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993873 CC(O)c1cc2c(N3CCC4(CCC4)CC3)c(C#N)c(=O)[nH]c2cn1 477982 6-(1-hydroxyethyl)-2-oxo-4-(7-azaspiro[3.5]nonane-7-yl)-1,2-dihydro-1,7-naphthyridin-3-carbonitrile ::US10889591, Compound 94::US11434248, Compound 94 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 12.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477982 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477982&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 138518543 442137596 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993874 CC(=O)c1cc2c(N3CCC4(CC4)CC3)c(C#N)c(=O)[nH]c2cn1 InChI=1S/C18H18N4O2/c1-11(23)14-8-12-15(10-20-14)21-17(24)13(9-19)16(12)22-6-4-18(2-3-18)5-7-22/h8,10H,2-7H2,1H3,(H,21,24) DAHRIIUFEIXMMA-UHFFFAOYSA-N 477983 6-acetyl-2-oxo-4-(6-azaspiro[2.5]octane-6-yl)-1,2-dihydro-1,7-naphthyridin-3-carbonitrile ::US10889591, Compound 95::US11434248, Compound 95 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 91.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477983 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477983&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027115 442137597 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993875 CNC(=O)c1cc2c(N3CCC4(CC4)CC3)c(C#N)c(=O)[nH]c2cn1 InChI=1S/C18H19N5O2/c1-20-17(25)13-8-11-14(10-21-13)22-16(24)12(9-19)15(11)23-6-4-18(2-3-18)5-7-23/h8,10H,2-7H2,1H3,(H,20,25)(H,22,24) ASKBDTWVZMSGNP-UHFFFAOYSA-N 477984 3-cyano-N-methyl-2-oxo-4-(6-azaspiro[2.5]octane-6-yl)-1,2-dihydro-1,7-naphthyridin-6-formamide ::US10889591, Compound 96::US11434248, Compound 96 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 11.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477984 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477984&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027116 442137598 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993876 OCCNC(=O)c1cc2c(N3CCC4(CC4)CC3)c(C#N)c(=O)[nH]c2cn1 InChI=1S/C19H21N5O3/c20-10-13-16(24-6-3-19(1-2-19)4-7-24)12-9-14(18(27)21-5-8-25)22-11-15(12)23-17(13)26/h9,11,25H,1-8H2,(H,21,27)(H,23,26) AWNHWSFXYGDQRW-UHFFFAOYSA-N 477985 3-cyano-N-(2-hydroxyethyl)-2-oxo-4-(6-aza-spiro[2.5]oct-6-yl)-1,2-dihydro-1,7-naphthyridin-6-carboxamide ::US10889591, Compound 97::US11434248, Compound 97 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 27.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477985 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477985&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027117 442137599 C04080 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993877 CCc1cc2c(N3CCC(C)(CC3)OC)c(C#N)c(=O)[nH]c2cn1 InChI=1S/C18H22N4O2/c1-4-12-9-13-15(11-20-12)21-17(23)14(10-19)16(13)22-7-5-18(2,24-3)6-8-22/h9,11H,4-8H2,1-3H3,(H,21,23) PELGRUUCXUGKFT-UHFFFAOYSA-N 477986 US10889591, Compound 107::US11434248, Compound 107 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 15.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477986 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477986&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027118 442137600 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993878 COC1(C)CCN(CC1)c1c(C#N)c(=O)[nH]c2cnc(cc12)C(C)O 477987 US10889591, Compound 108::US11434248, Compound 108 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 4.00 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477987 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477987&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 138518226 442137601 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993879 COC1(C)CCN(CC1)c1c(C#N)c(=O)[nH]c2cnc(cc12)C(C)(C)O InChI=1S/C19H24N4O3/c1-18(2,25)15-9-12-14(11-21-15)22-17(24)13(10-20)16(12)23-7-5-19(3,26-4)6-8-23/h9,11,25H,5-8H2,1-4H3,(H,22,24) RRVBTZBMTWTIBV-UHFFFAOYSA-N 477988 US10889591, Compound 109::US11434248, Compound 109 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 38.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477988 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477988&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027119 442137602 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993880 CSc1ncc2[nH]c(=O)c(C#N)c(N3CCC4(CC4)CC3)c2n1 InChI=1S/C16H17N5OS/c1-23-15-18-9-11-12(20-15)13(10(8-17)14(22)19-11)21-6-4-16(2-3-16)5-7-21/h9H,2-7H2,1H3,(H,19,22) LHPGZHCZYPNGAB-UHFFFAOYSA-N 477989 US10889591, Compound 129::US11434248, Compound 129 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 11.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477989 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477989&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027120 442137603 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993881 COC1(C)CCN(CC1)c1c(C#N)c(=O)[nH]c2cnc(cc12)C(O)C1CC1 477990 6-(cyclopropyl(hydroxy)methyl)-4-(4-methoxy-4-methylpiperidin-1-yl)-2-oxo-1,2-dihydro-1,7-naphthyridin-3-carbonitrile ::US10889591, Compound 130::US11434248, Compound 130 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 3.00 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477990 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477990&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027121 442137604 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993882 CNC(=O)c1cc2c(N3CCC(C)(CC3)OC)c(C#N)c(=O)[nH]c2cn1 InChI=1S/C18H21N5O3/c1-18(26-3)4-6-23(7-5-18)15-11-8-13(17(25)20-2)21-10-14(11)22-16(24)12(15)9-19/h8,10H,4-7H2,1-3H3,(H,20,25)(H,22,24) YPWIJSNKQBQICA-UHFFFAOYSA-N 477991 US10889591, Compound 131::US11434248, Compound 131 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 11.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477991 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477991&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027122 442137605 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993883 COC1(C)CCN(CC1)c1c(C#N)c(=O)[nH]c2cnc(C=C)cc12 InChI=1S/C18H20N4O2/c1-4-12-9-13-15(11-20-12)21-17(23)14(10-19)16(13)22-7-5-18(2,24-3)6-8-22/h4,9,11H,1,5-8H2,2-3H3,(H,21,23) NYORVFNAZITDJE-UHFFFAOYSA-N 477992 4-(4-methoxy-4-methylpiperidin-1-yl)-2-oxo-6-vinyl-1,2-dihydro-1,7-naphthyridin-3-carbonitrile ::US10889591, Compound 132::US11434248, Compound 132 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 24.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=477992 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=477992&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027123 442137606 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993884 CC(C)C(O)c1cc2c(N3CCC4(CC4)CC3)c(C#N)c(=O)[nH]c2cn1 478002 US10889591, Compound 134::US11434248, Compound 134 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 21.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=478002 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=478002&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027124 442137616 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993885 COC1(C)CCN(CC1)c1c(C#N)c(=O)[nH]c2cnc(cc12)C(=O)NCCN InChI=1S/C19H24N6O3/c1-19(28-2)3-7-25(8-4-19)16-12-9-14(18(27)22-6-5-20)23-11-15(12)24-17(26)13(16)10-21/h9,11H,3-8,20H2,1-2H3,(H,22,27)(H,24,26) LWMUDZYSGINBJM-UHFFFAOYSA-N 478003 US10889591, Compound 138::US11434248, Compound 138 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 14.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=478003 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=478003&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027125 442137617 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993886 COC1(C)CCN(CC1)c1c(C#N)c(=O)[nH]c2cnc(cc12)C(=O)NCCN(C)C InChI=1S/C21H28N6O3/c1-21(30-4)5-8-27(9-6-21)18-14-11-16(20(29)23-7-10-26(2)3)24-13-17(14)25-19(28)15(18)12-22/h11,13H,5-10H2,1-4H3,(H,23,29)(H,25,28) ZPFCIKCUXHVUPD-UHFFFAOYSA-N 478004 3-cyano-N-(2-(dimethylamino)ethyl)-4-(4-methoxy-4-methylpiperidin-1-yl)-2-oxo-1,2-dihydro-1,7-naphthyridin-6-carboxamide ::US10889591, Compound 139::US11434248, Compound 139 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 69.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=478004 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=478004&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027126 442137618 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993887 COC1(C)CCN(CC1)c1c(C#N)c(=O)[nH]c2cnc(cc12)C(=O)NCCN1CCCC1 InChI=1S/C23H30N6O3/c1-23(32-2)5-10-29(11-6-23)20-16-13-18(22(31)25-7-12-28-8-3-4-9-28)26-15-19(16)27-21(30)17(20)14-24/h13,15H,3-12H2,1-2H3,(H,25,31)(H,27,30) UVXZPQPDHOIADD-UHFFFAOYSA-N 478005 3-cyano-4-(4-methoxy-4-methylpiperidin-1-yl)-2-oxo-N-(2-(pyrrolidin-1-yl)ethyl)-1,2-dihydro-1,7-naphthyridin-6-carboxamide ::US10889591, Compound 140::US11434248, Compound 140 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 61.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=478005 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=478005&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027127 442137619 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993888 COC1(C)CCN(CC1)c1c(C#N)c(=O)[nH]c2cnc(cc12)C(=O)NCC1CCN(C)CC1 InChI=1S/C24H32N6O3/c1-24(33-3)6-10-30(11-7-24)21-17-12-19(26-15-20(17)28-22(31)18(21)13-25)23(32)27-14-16-4-8-29(2)9-5-16/h12,15-16H,4-11,14H2,1-3H3,(H,27,32)(H,28,31) GIHGFKNONUGKIF-UHFFFAOYSA-N 478006 3-cyano-4-(4-methoxy-4-methylpiperidin-1-yl)-N-((1-methylpiperidin-4-yl)methyl)-2-oxo-1,2-dihydro-1,7-naphthyridin-6-carboxamide ::US10889591, Compound 141::US11434248, Compound 141 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 52.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=478006 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=478006&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027128 442137620 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993889 COC1(C)CCN(CC1)c1c(C#N)c(=O)[nH]c2cnc(cc12)C(=O)NC1CN(C)C1 InChI=1S/C21H26N6O3/c1-21(30-3)4-6-27(7-5-21)18-14-8-16(20(29)24-13-11-26(2)12-13)23-10-17(14)25-19(28)15(18)9-22/h8,10,13H,4-7,11-12H2,1-3H3,(H,24,29)(H,25,28) GXLGSGBTTZNQIS-UHFFFAOYSA-N 478011 3-cyano-4-(4-methoxy-4-methylpiperidin-1-yl)-N-(1-methylazetidin-3-yl)-2-oxo-1,2-dihydro-1,7-naphthyridin-6-carboxamide ::US10889591, Compound 142::US11434248, Compound 142 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 85.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=478011 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=478011&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027129 442137625 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993890 COC1(C)CCN(CC1)c1c(C#N)c(=O)[nH]c2cnc(cc12)C(=O)NCC(O)CO 478012 3-cyano-N-(2,3-dihydroxypropyl)-4-(4-methoxy-4-methylpiperidin-1-yl)-2-oxo-1,2-dihydro-1,7-naphthyridin-6-carboxamide ::US10889591, Compound 144::US11434248, Compound 144 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 25.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=478012 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=478012&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027130 442137626 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993891 COCCOc1cc2c(N3CCC(C)(CC3)OC)c(C#N)c(=O)[nH]c2cn1 InChI=1S/C19H24N4O4/c1-19(26-3)4-6-23(7-5-19)17-13-10-16(27-9-8-25-2)21-12-15(13)22-18(24)14(17)11-20/h10,12H,4-9H2,1-3H3,(H,22,24) WBCCCYHSQKKJIO-UHFFFAOYSA-N 478013 US10889591, Compound 145::US11434248, Compound 145 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 31.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=478013 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=478013&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027131 442137627 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993892 CN(C)C(=O)c1cc2c(N3CCC4(CC4)CC3)c(C#N)c(=O)[nH]c2cn1 InChI=1S/C19H21N5O2/c1-23(2)18(26)14-9-12-15(11-21-14)22-17(25)13(10-20)16(12)24-7-5-19(3-4-19)6-8-24/h9,11H,3-8H2,1-2H3,(H,22,25) VLRRXEYGQCDEPY-UHFFFAOYSA-N 478014 3-cyano-N,N-dimethyl-2-oxo-4-(6-azaspiro[2.5]octane-6-yl)-1,2-dihydro-1,7-naphthyridin-6-carboxamide ::US10889591, Compound 149::US11434248, Compound 149 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 60.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=478014 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=478014&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027132 442137628 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993893 COC1(C)CCN(CC1)c1c(C#N)c(=O)[nH]c2cnc(Cl)cc12 InChI=1S/C16H17ClN4O2/c1-16(23-2)3-5-21(6-4-16)14-10-7-13(17)19-9-12(10)20-15(22)11(14)8-18/h7,9H,3-6H2,1-2H3,(H,20,22) QFZKDKDZGYBSLH-UHFFFAOYSA-N 478015 US10889591, Compound 151::US11434248, Compound 151 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 38.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=478015 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=478015&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027133 442137629 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993894 O=c1[nH]c2cnccc2c(N2CC[C@H](C2)n2cncn2)c1C#N 478017 US10889591, Compound 154::US11434248, Compound 154 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 8.00 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=478017 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=478017&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027134 442137631 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993895 CC(O)c1cc2c(N3CC[C@H](C3)n3cccn3)c(C#N)c(=O)[nH]c2cn1 478018 US10889591, Compound 156::US11434248, Compound 156 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 22.0 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=478018 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=478018&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027135 442137632 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993896 COC1(C)CCN(CC1)c1c(C#N)c(=O)[nH]c2cnc(C)cc12 InChI=1S/C17H20N4O2/c1-11-8-12-14(10-19-11)20-16(22)13(9-18)15(12)21-6-4-17(2,23-3)5-7-21/h8,10H,4-7H2,1-3H3,(H,20,22) UNEKXSMKACSFHR-UHFFFAOYSA-N 478019 4-(4-methoxy-4-methylpiperidin-1-yl)-6-methyl-2-oxo-1,2-dihydro-1,7-naphthyridin-3-carbonitrile ::US10889591, Compound 158::US11434248, Compound 158 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 9.00 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=478019 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=478019&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027136 442137633 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0 993897 COC1(C)CCN(CC1)c1c(C#N)c(=O)[nH]c2cnc(cc12)C(=O)N(C)C InChI=1S/C19H23N5O3/c1-19(27-4)5-7-24(8-6-19)16-12-9-14(18(26)23(2)3)21-11-15(12)22-17(25)13(16)10-20/h9,11H,5-8H2,1-4H3,(H,22,25) MPDMCAKRXVXXSL-UHFFFAOYSA-N 478020 3-cyano-4-(4-methoxy-4-methylpiperidin-1-yl)-N,N-dimethyl-2-oxo-1,2-dihydro-1,7-naphthyridin-6-carboxamide ::US10889591, Compound 162::US11434248, Compound 162 High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A Homo sapiens 10.00 US Patent 10.7270/Q2QR5175 aid1805178 US10889591 Wu, F; Li, L; Yang, X 1/12/2021 8/9/2021 Nanjing TransThera Biosciences Co. Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=478020 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5068&target=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=478020&enzyme=High+affinity+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+9A&column=ki&startPg=0&Increment=50&submit=Search 156027137 442137634 1 MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRREGAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA 2HD1,2YY2,3DY8,3DYL,3DYN,3DYQ,3DYS,3JSI,3JSW,3K3E,3K3H,4E90,4G2J,4G2L,4GH6,6A3N,6LZZ,8BPY High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A PDE9A_HUMAN O76083 B2RBI5 B4DFI5 D3DSJ8 D3DSJ9 O75490 O75491 O95225 Q53Y40 Q5QD39 Q86SF7 Q86SI6 Q86SJ3 Q86WN3 Q86WN4 Q86WN5 Q86WN6 Q86WN7 Q86WN8 Q86WN9 Q86WP0